These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 29844451)
1. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice. Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451 [TBL] [Abstract][Full Text] [Related]
2. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy. Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934 [TBL] [Abstract][Full Text] [Related]
3. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy. Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269 [TBL] [Abstract][Full Text] [Related]
4. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products. Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627 [TBL] [Abstract][Full Text] [Related]
5. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640 [TBL] [Abstract][Full Text] [Related]
6. Bupleurum polysaccharides ameliorated renal injury in diabetic mice associated with suppression of HMGB1-TLR4 signaling. Liu ZZ; Weng HB; Zhang LJ; Pan LY; Sun W; Chen HX; Chen MY; Zeng T; Zhang YY; Chen DF; Li H Chin J Nat Med; 2019 Sep; 17(9):641-649. PubMed ID: 31526499 [TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway. Good DW; George T; Watts BA Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706 [TBL] [Abstract][Full Text] [Related]
9. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4. Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181 [TBL] [Abstract][Full Text] [Related]
10. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway. Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529 [TBL] [Abstract][Full Text] [Related]
11. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641 [TBL] [Abstract][Full Text] [Related]
13. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products. Mazarati A; Maroso M; Iori V; Vezzani A; Carli M Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699 [TBL] [Abstract][Full Text] [Related]
14. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4. Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586 [TBL] [Abstract][Full Text] [Related]
15. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney. Manigrasso MB; Friedman RA; Ramasamy R; D'Agati V; Schmidt AM Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1601-F1612. PubMed ID: 30132346 [TBL] [Abstract][Full Text] [Related]
16. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats. Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180 [TBL] [Abstract][Full Text] [Related]
17. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs. Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829 [TBL] [Abstract][Full Text] [Related]
18. Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway. Shu A; Du Q; Chen J; Gao Y; Zhu Y; Lv G; Lu J; Chen Y; Xu H Chem Biol Interact; 2021 Oct; 348():109625. PubMed ID: 34416245 [TBL] [Abstract][Full Text] [Related]
19. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage. Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322 [TBL] [Abstract][Full Text] [Related]
20. Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor. Dinarvand P; Hassanian SM; Qureshi SH; Manithody C; Eissenberg JC; Yang L; Rezaie AR Blood; 2014 Feb; 123(6):935-45. PubMed ID: 24255918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]